首页> 美国卫生研究院文献>Postgraduate Medical Journal >Failure of conventional chemotherapy in aggressive lymphomas.
【2h】

Failure of conventional chemotherapy in aggressive lymphomas.

机译:侵袭性淋巴瘤常规化疗失败。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Between 1975 and 1982 in 2 centres in Glasgow, 53 previously untreated patients with aggressive non-Hodgkin's lymphomas received chemotherapy consisting of one of the following regimens-CVP, MOPP, CHOP or BACOP. Twenty nine patients (55%) entered complete remission (CR), 20 (38%) had partial remission (PR) and 4 (7%) had progressive disease (PD). Of the 29 patients in CR, 9 have relapsed and died, 5 died of infection, 4 died of non-malignant causes, and 11 (21%) remain alive and disease free. The median survival for the CR group is 40 months. All of the patients in the PR and PD group are dead, median survival 11 months. These chemotherapy regimens will cure only the minority of patients with aggressive lymphomas and the use of more intensive regimens is indicated.
机译:在1975年至1982年之间,格拉斯哥的2个中心对53例先前未经治疗的侵袭性非霍奇金淋巴瘤患者进行了化学治疗,其中包括以下方案之一:CVP,MOPP,CHOP或BACOP。进入完全缓解(CR)的患者有29例(55%),部分缓解(PR)的患者20例(38%),进行性疾病(PD)的患者4例(7%)。在这29例CR患者中,有9例复发并死亡,5例死于感染,4例死于非恶性原因,还有11例(21%)仍然活着并且没有疾病。 CR组的中位生存期为40个月。 PR和PD组所有患者均死亡,中位生存期为11个月。这些化学疗法只能治愈少数患有侵袭性淋巴瘤的患者,因此需要使用更严格的疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号